Berkeley Lights, Inc. (BLI)
$2.04
-0.07 (-3.32%)
Rating:
Recommendation:
-
| Symbol | BLI |
|---|---|
| Price | $2.04 |
| Beta | 1.452 |
| Volume Avg. | 0.94M |
| Market Cap | 140.484M |
| Shares () | - |
| 52 Week Range | 1.825-10.29 |
| 1y Target Est | - |
| DCF Unlevered | BLI DCF -> | |
|---|---|---|
| DCF Levered | BLI LDCF -> | |
| ROE | -41.62% | Strong Sell |
| ROA | -34.54% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 48.49% | Neutral |
| P/E | - | |
| P/B | 0.88 | Buy |
Latest BLI news
About
Download (Excel)Dr. Eric D. Hobbs Ph.D.
Healthcare
Biotechnology
NASDAQ Global Select
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.